Ottawa bolsters BC biotech company as US tariffs hit sector hard

The sciences are an often-overlooked sector that has been hit hard by U.S. tariffs. In British Columbia, the infrastructure and the science to create “Canadian-patented” products are ramping up with the help of new funding from Ottawa. And one biotech firm is front and centre